375
Views
6
CrossRef citations to date
0
Altmetric
Expert Opinion

Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures

, &
Pages 467-476 | Published online: 11 Sep 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kim Lawson. (2016) Potential drug therapies for the treatment of fibromyalgia. Expert Opinion on Investigational Drugs 25:9, pages 1071-1081.
Read now
MA Martínez-Granero, A García-Pérez & F Montañes. (2010) Levetiracetam as an alternative therapy for Tourette syndrome. Neuropsychiatric Disease and Treatment 6, pages 309-316.
Read now

Articles from other publishers (4)

Itzel Jatziri Contreras-García, Noemí Cárdenas-Rodríguez, Antonio Romo-Mancillas, Cindy Bandala, Sergio R. Zamudio, Saúl Gómez-Manzo, Beatriz Hernández-Ochoa, Julieta Griselda Mendoza-Torreblanca & Luz Adriana Pichardo-Macías. (2022) Levetiracetam Mechanisms of Action: From Molecules to Systems. Pharmaceuticals 15:4, pages 475.
Crossref
Marwa I. Hegazy I. Hegazy, Aman M. Asaad, Lila A. Rashed & Hanaa H. Ahmed. (2022) Combined Treatment of Levetiracetam and Mesenchymal Stem Cells Reverses the Biochemical Aberrations in the Acute Phase of Epilepsy Induced by Pilocarpine in Rats. Biomedical and Pharmacology Journal 15:1, pages 91-115.
Crossref
Г.И. Наумова. (2021) Prospects of the Use of Levetiracetam with Controlled Release of Active Substance: a New Form of Levipil XR in Clinical Practice. Неврология и нейрохирургия. Восточная Европа:2, pages 268-291.
Crossref
Utkarsh Bhutani, Tithi Basu & Saptarshi Majumdar. (2021) Oral Drug Delivery: Conventional to Long Acting New-Age Designs. European Journal of Pharmaceutics and Biopharmaceutics 162, pages 23-42.
Crossref